Downlands Calcium Borogluconate 40% w/v CM Solution for Injection

Composition

Active Substance:

Each ml contains:

400 mg Calcium Borogluconate and 50 mg Magnesium Hypophosphite Hexahydrate.

Each 400 ml contains:

11.9 g calcium (provided by calcium gluconate and calcium borogluconate) and 1.85 g magnesium hypophosphite hexahydrate)

Also contains 6.84% w/v boric acid.

Excipients:

For the full list of excipients, see section 6.1

6.1 List of excipients

Sodium Bicarbonate 10% or Boric Acid 5% (for pH adjustment)

Water for Injections

3

Pharmaceutical form

Solution for Injection A clear pale yellow solution

3

Pharmacological properties

Pharmacotherapeutic group: Mineral supplements, Calcium, Calcium, combinations with other drugs

ATC Vet Code: QA12AX

5.1 Pharmacodynamic properties

Calcium Borogluconate and Magnesium Hypophosphite are soluble salts of calcium and magnesium respectively used extensively in fluid infusions in correction of metabolic disturbances. On parenteral administration they rapidly increase plasma concentrations of calcium, magnesium and phosphorus. This is effective in the treatment of hypocalcaemia with associated magnesium and phosphorus deficiencies.

3

Target species

Cattle

3

Indications

Treatment of hypocalcaemia in cattle where increased blood magnesium levels are required.

3

Dosage

Administer by subcutaneous or slow intravenous injection

Cattle : 200 - 400 ml

3

Contraindications

Do not use in cases of hypersensitivity to the active substances or to any of the excipients.

3

Adverse reactions

Occasional temporary swelling may occur at sites of subcutaneous administration.

3

Warnings

i) Special precautions for use in animals The solution should be warmed to body temperature before administration.

Intravenous injections should be given slowly in order to avoid possible neuromuscular dysfunction and cardiac insufficiency. Normal aseptic precautions should be observed. Sites of subcutaneous administration should be messaged gently.

ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals

Care should be taken to avoid accidental self-injection. If accidental self- injection occurs, seek medical advice.

Wash hands after use.

3

Use during pregnancy, lactation or lay

Safe for use during pregnancy and lactation.

3

Interactions

None

3

Overdose

Not applicable.

3

Special warnings

None

3

Withdrawal period

Meat and offal: Zero days Milk: Zero hours

3

Incompatibilities

In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.

3

Immediate packaging

The product is marketed in either 400 ml Amber Type III glass vials sealed using black rubber wads and aluminium screw caps, or 400ml polypropylene containers sealed with bromobutyl bungs and aluminium caps.

3

Storage

Do not store above 25oC. Protect from light.

This product does not contain an antimicrobial preservative. Any solution remaining in the vial following withdrawal of the required dose should be discarded.

3

Shelf life

Shelf life of the veterinary medicinal product as packaged for sale:

Glass bottles 2 years.

Polypropylene vials 18 months

3

Disposal of unused product

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

3

Additional information

Vm 02000/4214

9 DATE OF FIRST AUTHORISATION

05 July 1999

10 DATE OF REVISION OF THE TEXT

July 2018

Approved: 27 July 2018

3

Registration holder

Norbrook Laboratories Limited

Station Works

Camlough Road

Newry

Co. Down

BT35 6JP

Northern Ireland

3